Surface Oncology, Inc.: meeting of 7 Sep 2023

Votes reported on Form N-PX, item by item

62 Form N-PX filers reported votes at the Surface Oncology, Inc. meeting of 7 Sep 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

3 vote records from 2 filers. No filer marked a management recommendation, so no against-management figure is reported. 2 filers reported this item without a management mark.

0.0% for0.0% against100.0% other2 filers0.0% for0.0% against100.0% other50 reported shares

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

68 vote records from 59 filers. 41 of the 56 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided

23.7% for71.2% against5.1% other73.2% against management59 filers52.7% for47.3% against47.3% against management14,906,829 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

18 vote records from 14 filers. 0 of the 14 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management14 filers100.0% for0.0% against0.0% against management3,542,240 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

20 vote records from 15 filers. 1 of the 15 filers that marked the item either way voted against management.

93.3% for6.7% against6.7% against management15 filers82.1% for17.9% against17.9% against management3,552,508 reported shares, counted once per item in this group

How the largest families voted

Family	2. Merger pay
Vanguard	Against *
BlackRock and iShares	Against *
Fidelity	Against *
State Street and SPDR	Against *
Franklin Templeton	Against *
Charles Schwab	Against *
Goldman Sachs	Split or no vote
Victory Capital	Against *
Guggenheim and Rydex	Against *
BNY Mellon	Against *
Federated Hermes	Against *
Macquarie and Delaware Funds	Against *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Surface Oncology, Inc. meeting?

62 Form N-PX filers reported votes at the meeting of 7 Sep 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Surface Oncology, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Surface Oncology, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Surface Oncology, Inc. with a meeting date within three days of 7 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.